- Home
- MDGL vs FLR Comparison
MDGL vs FLR Comparison
Compare MDGL & FLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- FLR
- Stock Information
- Founded
- MDGL 2011
- FLR 1912
- Country
- MDGL United States
- FLR United States
- Employees
- MDGL N/A
- FLR N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- FLR Military/Government/Technical
- Sector
- MDGL Health Care
- FLR Industrials
- Exchange
- MDGL Nasdaq
- FLR Nasdaq
- Market Cap
- MDGL 6.8B
- FLR 5.9B
- IPO Year
- MDGL N/A
- FLR N/A
- Fundamental
- Price
- MDGL $267.56
- FLR $41.04
- Analyst Decision
- MDGL Strong Buy
- FLR Strong Buy
- Analyst Count
- MDGL 10
- FLR 7
- Target Price
- MDGL $420.63
- FLR $45.71
- AVG Volume (30 Days)
- MDGL 367.0K
- FLR 3.0M
- Earning Date
- MDGL 05-01-2025
- FLR 05-02-2025
- Dividend Yield
- MDGL N/A
- FLR N/A
- EPS Growth
- MDGL N/A
- FLR 563.49
- EPS
- MDGL N/A
- FLR 10.64
- Revenue
- MDGL $317,383,000.00
- FLR $16,563,000,000.00
- Revenue This Year
- MDGL $285.43
- FLR $10.84
- Revenue Next Year
- MDGL $63.77
- FLR $6.38
- P/E Ratio
- MDGL N/A
- FLR $3.86
- Revenue Growth
- MDGL N/A
- FLR 7.16
- 52 Week Low
- MDGL $200.63
- FLR $29.20
- 52 Week High
- MDGL $377.46
- FLR $60.10
- Technical
- Relative Strength Index (RSI)
- MDGL 31.79
- FLR 69.42
- Support Level
- MDGL $281.76
- FLR $37.34
- Resistance Level
- MDGL $295.60
- FLR $38.83
- Average True Range (ATR)
- MDGL 12.60
- FLR 1.11
- MACD
- MDGL -2.58
- FLR 0.32
- Stochastic Oscillator
- MDGL 3.22
- FLR 95.89
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About FLR Fluor Corporation
Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services. The firm serves a wide range of end markets, including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $16.3 billion in revenue in 2024.